NEW YORK, March 22, 2023 /PRNewswire/ -- The bacterial disease diagnostics market size is forecast to grow by USD 3,766.05 million between 2022 and 2027. However, the growth momentum will be decelerating at a CAGR of 6.28% during the forecast period. The growth of the market is driven by factors such as the high prevalence of infectious diseases, the integration of digital health in rapid diagnostics for bacterial disease, and the growing number of merger and acquisition (M&A) activities.

The number of disease outbreaks has increased significantly over the past few years. Factors such as malnutrition, poor sanitation, poor water quality, and the lack of proper healthcare systems have increased the prevalence of infectious diseases. For instance, according to WHO, in 2020, an estimated 10 million people fell ill with tuberculosis (TB) worldwide. Similarly, the incidence of infectious diseases such as TB, malaria, and hepatitis is increasing worldwide. The rise in the incidence of various infectious diseases has increased the demand for bacterial disease diagnostics. All these factors are driving the growth of the market in focus. For more insights on the historic data (2017 to 2021) and forecast market size (2023 to 2027) – Request a report sample

Regional Analysis

By region, the global bacterial disease diagnostics market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America will account for 49% of market growth during the forecast period. The increase in the prevalence of bacterial diseases such as TB, meningitis, and pneumonia has been crucial in driving the growth of the regional market. The development of new antibacterial drugs and the increase in funding for the development of new therapies are other major factors supporting the growth of the bacterial disease diagnostics market in North America.

Company Profiles

The global bacterial disease diagnostics market is fragmented due to the presence of several global and regional players. Key vendors are developing a comprehensive range of advanced bacterial disease diagnostics to strengthen their position and cater to the demands of end-users. Prominent vendors are trying to build a strong customer base by distributing the products through subsidiaries and other distribution channels worldwide. Besides, the market is witnessing collaborations and tie-ups of vendors with clinics and practitioners. All these factors will intensify the competition in the market during the forecast period.

The bacterial disease diagnostics market report includes information on the key products and recent developments of leading vendors, including:

• Abbott Laboratories - The company offers bacterial disease diagnostics such as Abbott RealTime SARS-C0V-2 assay.
• Accelerate Diagnostics Inc. - The company offers bacterial disease diagnostics such as Accelerate Pheno system.
• Becton Dickinson and Co. - The company offers bacterial disease diagnostics such as BD Directigen immunoassay test kits.
• Bio Rad Laboratories Inc. - The company offers bacterial disease diagnostics such as pGLO Bacterial Transformation Kit.

Competitive Analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample

Market Segmentation

• By product, the market is segmented into consumables and instruments.
• By end-user, the market is segmented into hospitals and labs.
• By geography, the market is segmented into North America, Europe, Asia, and Rest of World (ROW).

Why Buy?

• Add credibility to strategy
• Analyzes competitor's offerings
• Get a holistic view of the market

Grow your profit margin with Technavio – Buy the Report!

What are the key data covered in this bacterial disease diagnostics market report?

• CAGR of the market during the forecast period.
• Detailed information on factors that will drive the growth of the market between 2023 and 2027
• Precise estimation of the size of the bacterial disease diagnostics market and its contribution to the parent market.
• Accurate predictions about upcoming trends and changes in consumer behavior.
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW).
• A thorough analysis of the market's competitive landscape and detailed information about vendors.
• Comprehensive analysis of factors that will challenge the growth of bacterial disease diagnostics market vendors.

Related Reports:

• The hemostasis diagnostics market size is expected to increase by USD 1.12 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.95%. The market is segmented by end-user (hospitals and clinics, independent diagnostic centers, and research and academic institutions) and geography (North America, Europe, Asia, and the Rest of World (ROW)).
• The allergy immunotherapies market is estimated to grow at a CAGR of 8.95% between 2022 and 2027. The size of the market is forecast to increase by USD 1,010.37 million. The market is segmented by product (SCIT and SLIT), type (allergic rhinitis, asthma, food allergy, and others), and geography (Europe, North America, Asia, and the Rest of World (ROW)).

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global bacterial disease diagnostics market 2017 - 2021
• Exhibit 18: Historic Market Size – Data Table on Global bacterial disease diagnostics market 2017 - 2021 ($ million)

• 4.2 Product Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.3 End-user Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments 
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)

• 6.2 Comparison by Product 
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product

• 6.3 Consumables - Market size and forecast 2022-2027
• Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)

• 6.4 Instruments - Market size and forecast 2022-2027
• Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Product 
• Exhibit 42: Market opportunity by Product ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments 
• Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)

• 7.2 Comparison by End-user 
• Exhibit 45: Chart on Comparison by End-user
• Exhibit 46: Data Table on Comparison by End-user

• 7.3 Hospitals - Market size and forecast 2022-2027
• Exhibit 47: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)

• 7.4 Labs - Market size and forecast 2022-2027
• Exhibit 51: Chart on Labs - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Labs - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Labs - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Labs - Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by End-user 
• Exhibit 55: Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 57: Chart on Market share by geography 2022-2027 (%)
• Exhibit 58: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 59: Chart on Geographic comparison
• Exhibit 60: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Canada - Market size and forecast 2022-2027
• Exhibit 81: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Canada - Year-over-year growth 2022-2027 (%)

• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.10 UK - Market size and forecast 2022-2027
• Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.11 Japan - Market size and forecast 2022-2027
• Exhibit 93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 97: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 98: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape 
• Exhibit 99: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 100: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 101: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 102: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 103: Matrix on vendor position and classification

• 12.3 Abbott Laboratories 
• Exhibit 104: Abbott Laboratories - Overview
• Exhibit 105: Abbott Laboratories - Business segments
• Exhibit 106: Abbott Laboratories - Key news
• Exhibit 107: Abbott Laboratories - Key offerings
• Exhibit 108: Abbott Laboratories - Segment focus

• 12.4 Accelerate Diagnostics Inc. 
• Exhibit 109: Accelerate Diagnostics Inc. - Overview
• Exhibit 110: Accelerate Diagnostics Inc. - Product / Service
• Exhibit 111: Accelerate Diagnostics Inc. - Key offerings

• 12.5 Becton Dickinson and Co. 
• Exhibit 112: Becton Dickinson and Co. - Overview
• Exhibit 113: Becton Dickinson and Co. - Business segments
• Exhibit 114: Becton Dickinson and Co. - Key news
• Exhibit 115: Becton Dickinson and Co. - Key offerings
• Exhibit 116: Becton Dickinson and Co. - Segment focus

• 12.6 Bio Rad Laboratories Inc. 
• Exhibit 117: Bio Rad Laboratories Inc. - Overview
• Exhibit 118: Bio Rad Laboratories Inc. - Business segments
• Exhibit 119: Bio Rad Laboratories Inc. - Key news
• Exhibit 120: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 121: Bio Rad Laboratories Inc. - Segment focus

• 12.7 bioMerieux SA 
• Exhibit 122: bioMerieux SA - Overview
• Exhibit 123: bioMerieux SA - Product / Service
• Exhibit 124: bioMerieux SA - Key offerings

• 12.8 Danaher Corp. 
• Exhibit 125: Danaher Corp. - Overview
• Exhibit 126: Danaher Corp. - Business segments
• Exhibit 127: Danaher Corp. - Key news
• Exhibit 128: Danaher Corp. - Key offerings
• Exhibit 129: Danaher Corp. - Segment focus

• 12.9 DiaSorin SpA 
• Exhibit 130: DiaSorin SpA - Overview
• Exhibit 131: DiaSorin SpA - Business segments
• Exhibit 132: DiaSorin SpA - Key news
• Exhibit 133: DiaSorin SpA - Key offerings
• Exhibit 134: DiaSorin SpA - Segment focus

• 12.10 EKF Diagnostics Holdings Plc 
• Exhibit 135: EKF Diagnostics Holdings Plc - Overview
• Exhibit 136: EKF Diagnostics Holdings Plc - Business segments
• Exhibit 137: EKF Diagnostics Holdings Plc - Key offerings
• Exhibit 138: EKF Diagnostics Holdings Plc - Segment focus

• 12.11 F. Hoffmann La Roche Ltd. 
• Exhibit 139: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 140: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 141: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 142: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 143: F. Hoffmann La Roche Ltd. - Segment focus

• 12.12 Hologic Inc. 
• Exhibit 144: Hologic Inc. - Overview
• Exhibit 145: Hologic Inc. - Business segments
• Exhibit 146: Hologic Inc. - Key news
• Exhibit 147: Hologic Inc. - Key offerings
• Exhibit 148: Hologic Inc. - Segment focus

• 12.13 Perkin Elmer Inc. 
• Exhibit 149: Perkin Elmer Inc. - Overview
• Exhibit 150: Perkin Elmer Inc. - Business segments
• Exhibit 151: Perkin Elmer Inc. - Key news
• Exhibit 152: Perkin Elmer Inc. - Key offerings
• Exhibit 153: Perkin Elmer Inc. - Segment focus

• 12.14 QIAGEN NV 
• Exhibit 154: QIAGEN NV - Overview
• Exhibit 155: QIAGEN NV - Product / Service
• Exhibit 156: QIAGEN NV - Key news
• Exhibit 157: QIAGEN NV - Key offerings

• 12.15 Quest Diagnostics Inc. 
• Exhibit 158: Quest Diagnostics Inc. - Overview
• Exhibit 159: Quest Diagnostics Inc. - Business segments
• Exhibit 160: Quest Diagnostics Inc. - Key offerings
• Exhibit 161: Quest Diagnostics Inc. - Segment focus

• 12.16 Siemens AG 
• Exhibit 162: Siemens AG - Overview
• Exhibit 163: Siemens AG - Business segments
• Exhibit 164: Siemens AG - Key news
• Exhibit 165: Siemens AG - Key offerings
• Exhibit 166: Siemens AG - Segment focus

• 12.17 Takara Bio Inc. 
• Exhibit 167: Takara Bio Inc. - Overview
• Exhibit 168: Takara Bio Inc. - Business segments
• Exhibit 169: Takara Bio Inc. - Key offerings
• Exhibit 170: Takara Bio Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 171: Inclusions checklist
• Exhibit 172: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 173: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 174: Research methodology
• Exhibit 175: Validation techniques employed for market sizing
• Exhibit 176: Information sources

• 13.5 List of abbreviations 
• Exhibit 177: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/bacterial-disease-diagnostics-market-size-to-increase-by-usd-3-766-05-million-between-2022-and-2027-growth-driven-by-high-prevalence-of-infectious-diseases---technavio-301777589.html

SOURCE Technavio